எகே பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எகே பல்கலைக்கழகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எகே பல்கலைக்கழகம் Today - Breaking & Trending Today

Noted Uyghur Folklore Professor Serving Prison Term in China's Xinjiang — Radio Free Asia


Photo courtesy of Akida Polat/Freemymom.org
An internationally recognized expert in Uyghur folklore and ethnographer who disappeared in China’s Xinjiang Uyghur Autonomous Region (XUAR) more than three years ago has been confirmed as being imprisoned by authorities, according to her former co-workers at Xinjiang University.
Rahile Dawut, 55, created and directed the university s Minorities Folklore Research Center and wrote dozens of articles in international journals and a number of books, including studies on Islamic sacred sites in Central Asia, and presented her work at conferences around the world.
An anthropologist by training, she disappeared in December 2017, believed to be arrested and detained in one of the many internment camps in a mass incarceration campaign launched that year by Chinese authorities, who to date have not provided information on her whereabouts or the charges against her. ....

New York , United States , South Sudan , South Korea , City Of , United Kingdom , Rahile Dawut , Tashpolat Teyip , Lisa Ross , Arslan Abdulla , Alimcan Inayet , Akida Polat , Antony Blinken , Mehriay Mamteli , Rachel Harris , Rakhile Dawut , Dege University , U Campaign For Uyghurs , Xinijang University , Xinjiang University , Uyghur Service , New York Times , University Of London , Washington Post , Congress On , Zhong Jinwen At Beijing Normal University ,

The Lancet: CoronaVac COVID-19 vaccine is safe and protects against disease, interim analysis


 E-Mail
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
The preliminary findings, published in The Lancet and presented at this year s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), indicate that CoronaVac induces a robust antibody response. No severe adverse events or deaths were reported among the more than 10,000 trial participants in Turkey, with most adverse events mild and occurring within 7 days of an injection. However, more research is needed to confirm vaccine efficacy in the long term, in a more diverse group of participants, and against emerging variants of concern. ....

Murat Akova , Academy Of Medical Sciences , Research Hospital , Marmara University , Kocaeli University , Hacettepe University Medical School , Karadeniz Technical University , Sinovac Life Sciences , Dicle University Yedikule Chest Diseases , Dege University , European Congress , Akdeniz University , Gaziantep University , University Of Oxford Astrazeneca , Turkish Health Institutes Association , Ankara University , Hacettepe University , Clinical Microbiology , Infectious Diseases , Professor Murat Akova , Turkish Health Institutes , Tepecik Training , Ankara Training , Suat Seren Chest Diseases , Surgery Training , City Hospital ,